Brentuximab Vedotin Biosimilar - Research Grade
Product Specifications
Background
Brentuximab vedotin is an ADC consisting of a CD30-directed antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma.
Product Name Alternative
MMAE
Host
CHO Cells
Reactivity
Human
Target
TNFRSF8 / CD30
Isotype
IgG1
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
More Discoveries
Explore Other Products
Browse additional items from our catalog
384480 96 Tests
SPARCL1 (SPARC Like Protein 1) BioAssayTM ELISA Kit (Human) discontinued
Sign In for Pricing
View Details 
K2619203 1.0 µg DNA
VPS37B sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details AMM12298VCF 100 µg
Dystrobrevin beta (DTNB) Mouse Monoclonal Antibody [Clone ID: LBI3C11]
Sign In for Pricing
View Details